-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NRX Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2017 to Q3 2024.
- NRX Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.62M, a 73.2% increase year-over-year.
- NRX Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$20.4M, a 43.5% increase year-over-year.
- NRX Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30.2M, a 24.2% increase from 2022.
- NRX Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.8M, a 57.3% increase from 2021.
- NRX Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$93.1M, a 79.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)